Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FE132
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,827
Award facts
- Contract value 100% obligated
- $13,826.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,826.69 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 mL pens with an ultimate completion date of December 1, 2025. This is a non-set-aside, competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies a comprehensive range of pharmaceuticals and medical supplies to support military healthcare systems and other government agencies.
Wegovy is a GLP-1 receptor agonist medication primarily used for weight management in eligible patients. This delivery order represents one of numerous pharmaceutical supply transactions AmerisourceBergen executes through its DLA prime vendor contract, which enables the company to fulfill medical supply needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The competitively awarded contract structure demonstrates AmerisourceBergen's capability to meet federal procurement requirements and reflects DLA's reliance on established pharmaceutical prime vendors to maintain consistent supply chains for military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FE132?
SPE2DR26FE132 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26FE132 worth?
The government has obligated $13,827 on SPE2DR26FE132.
Is contract SPE2DR26FE132 an order under another contract?
Yes. SPE2DR26FE132 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FE132 competed?
The extent of competition for SPE2DR26FE132 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award